Refine
Document Type
- Article (46)
- Doctoral Thesis (1)
Language
- English (47) (remove)
Has Fulltext
- yes (47)
Is part of the Bibliography
- no (47)
Keywords
- - (37)
- plasma medicine (25)
- reactive oxygen species (16)
- ROS (14)
- cold physical plasma (11)
- kINPen (8)
- reactive oxygen and nitrogen species (7)
- cold atmospheric pressure plasma (5)
- oncology (5)
- CAP (4)
- RNS (4)
- cytokines (4)
- apoptosis (3)
- chemokines (3)
- cold atmospheric plasma (3)
- CRISPR/Cas9 genome editing (2)
- HL-60 (2)
- THP-1 (2)
- anticancer drugs (2)
- cancer (2)
- cancer therapy (2)
- cerebral cavernous malformation (2)
- combination therapy (2)
- mesenchymal stromal cells (2)
- metastasis (2)
- osteosarcoma (2)
- skin cancer (2)
- Antimicrobial (1)
- Apoptosis (1)
- Atmospheric pressure plasma (1)
- BRAF (1)
- Biofilm (1)
- CAL 78 (1)
- CAM (1)
- CCL17 (1)
- CCL22 (1)
- CCM1 (1)
- CCM1/KRIT1 (1)
- CRISPR/Cas9 (1)
- Cancer (1)
- Cerebral cavernous malformations (1)
- Co-culture (1)
- Cold physical plasma (1)
- Dielectric barrier discharge (1)
- Ewing’s sarcoma (1)
- HNSCC (1)
- Hsp27 (1)
- Kaltes Plasma (1)
- LNCaP (1)
- Leukozyten (1)
- M2 macrophages (1)
- MNT-1 (1)
- MidiPLexc (1)
- NSC59984 (1)
- Oncology (1)
- PC3 (1)
- PDA6606 (1)
- PEF (1)
- PTW (1)
- Plasmamedizin (1)
- RNA sequencing (1)
- RNA-Seq (1)
- Reactive oxygen and nitrogen species (1)
- SK-MEL-28 (1)
- SKH1 mouse model (1)
- SW 1353 (1)
- Surface barrier discharge plasma source (1)
- T-cells (1)
- TAMs (1)
- TUNEL assay (1)
- Tumor-like behavior (1)
- Urology (1)
- Wound management (1)
- Wundheilung (1)
- allografts (1)
- antimicrobial (1)
- antimicrobial therapy (1)
- arthroplasty (1)
- atmospheric pressure argon plasma jet (1)
- biofilm degradation (1)
- blood outgrowth endothelial cells (1)
- brain tumor (1)
- cancellous bone (1)
- cancer immunity (1)
- caspase-3/7 assay (1)
- cell migration (1)
- chaperones (1)
- chondrosarcoma (1)
- chronic wounds (1)
- cluster formation (1)
- cold argon plasma (1)
- cold plasma (1)
- colorectal cancer (1)
- damage-associated molecular patterns (1)
- decontamination (1)
- dermal full-thickness wounds (1)
- dermatology (1)
- endothelial cells VEGF (1)
- endothelial-specific gene expression (1)
- epithelial-to-mesenchymal transition (1)
- food production industry (1)
- food spoilage (1)
- gas plasma technology (1)
- growth inhibition (1)
- growth inhibitory effect (1)
- head and neck squamous cell carcinoma (1)
- heat-shock proteins (1)
- hemostasis (1)
- hydrogen peroxide (1)
- hypochlorous acid (1)
- iPSC-derived endothelial cells (1)
- iPSCs (1)
- immunogenicity (1)
- immunomodulation (1)
- inactivation (1)
- infected wounds (1)
- inflammation (1)
- kINPen MED (1)
- kINPen plasma jet (1)
- keratinocytes (1)
- leucocytes (1)
- live/dead cell imaging (1)
- macrophages (1)
- mass spectrometry (1)
- matrix metalloproteinase (1)
- medical gas plasma technology (1)
- membrane functionality (1)
- membrane integrity (1)
- migration (1)
- moDCs (1)
- monocytes (1)
- mucosal diseases (1)
- osteogenic differentiation (1)
- pancreatic cancer (1)
- patient-derived xenografts (1)
- peptidases (1)
- peroxynitrite (1)
- plasma discharge (1)
- plasma oncology (1)
- plasma sources (1)
- post-translational modifications (1)
- radius cell migration assay (1)
- reactive nitrogen species (1)
- redox regulation (1)
- resin (1)
- risk evaluation (1)
- screening (1)
- skeletal regeneration (1)
- surface modification (1)
- sustainability (1)
- synchrotron radiation computed tomography (1)
- tumor immunology (1)
- tumor microenvironment (TME) (1)
- tumor spheroids (1)
- tumor-associated macrophages (1)
- viability (1)
- von Willebrand factor (1)
- wound healing (1)
Institute
- Klinik und Poliklinik für Chirurgie Abt. für Viszeral-, Thorax- und Gefäßchirurgie (11)
- Klinik und Poliklinik für Mund-, Kiefer- und Gesichtschirurgie/Plastische Operationen (10)
- Klinik und Poliklinik für Chirurgie Abt. für Unfall- und Wiederherstellungschirurgie (7)
- Institut für Hygiene und Umweltmedizin (5)
- Klinik und Poliklinik für Orthopädie und Orthopädische Chirurgie (3)
- Klinik und Poliklinik für Urologie (3)
- Abteilung für Mikrobiologie und Molekularbiologie (2)
- Institut für Humangenetik (2)
- Institut für Immunologie u. Transfusionsmedizin - Abteilung Immunologie (1)
- Institut für Mikrobiologie - Abteilung für Genetik & Biochemie (1)
Publisher
on-healing wounds continue to be a clinical challenge for patients and medical staff.
These wounds have a heterogeneous etiology, including diabetes and surgical trauma wounds. It is
therefore important to decipher molecular signatures that reflect the macroscopic process of wound
healing. To this end, we collected wound sponge dressings routinely used in vacuum assisted therapy
after surgical trauma to generate wound-derived protein profiles via global mass spectrometry.
We confidently identified 311 proteins in exudates. Among them were expected targets belonging to
the immunoglobulin superfamily, complement, and skin-derived proteins, such as keratins. Next to
several S100 proteins, chaperones, heat shock proteins, and immune modulators, the exudates
presented a number of redox proteins as well as a discrete neutrophil proteomic signature, including
for example cathepsin G, elastase, myeloperoxidase, CD66c, and lipocalin 2. We mapped over 200
post-translational modifications (PTMs; cysteine/methionine oxidation, tyrosine nitration, cysteine
trioxidation) to the proteomic profile, for example, in peroxiredoxin 1. Investigating manually
collected exudates, we confirmed presence of neutrophils and their products, such as microparticles
and fragments containing myeloperoxidase and DNA. These data confirmed known and identified
less known wound proteins and their PTMs, which may serve as resource for future studies on
human wound healing
Osteosarcoma and Ewing’s sarcoma are the most common malignant bone tumors.Conventional therapies such as polychemotherapy, local surgery, and radiotherapy improve theclinical outcome for patients. However, they are accompanied by acute and chronic side effectsthat affect the quality of life of patients, motivating novel research lines on therapeutic optionsfor the treatment of sarcomas. Previous experimental work with physical plasma operated atbody temperature (cold atmospheric plasma, CAP) demonstrated anti-oncogenic effects on differentcancer cell types. This study investigated the anti-cancer effect of CAP on two bone sarcomaentities, osteosarcoma and Ewing’s sarcoma, which were represented by four cell lines (U2-OS,MNNG/HOS, A673, and RD-ES). A time-dependent anti-proliferative effect of CAP on all cell lineswas observed. CAP-induced alterations in cell membrane functionality were detected by performinga fluorescein diacetate (FDA) release assay and an ATP release assay. Additionally, modifications ofthe cell membrane and modifications in the actin cytoskeleton composition were examined usingfluorescence microscopy monitoring dextran-uptake assay and G-/F-actin distribution. Furthermore,the CAP-induced induction of apoptosis was determined by TUNEL and active caspases assays.The observations suggest that a single CAP treatment of bone sarcoma cells may have significantanti-oncogenic effects and thus may be a promising extension to existing applications.
Summary
The susceptibility of Candida albicans biofilms to a non‐thermal plasma treatment has been investigated in terms of growth, survival and cell viability by a series of in vitro experiments. For different time periods, the C. albicans strain SC5314 was treated with a microwave‐induced plasma torch (MiniMIP). The MiniMIP treatment had a strong effect (reduction factor (RF) = 2.97 after 50 s treatment) at a distance of 3 cm between the nozzle and the superior regions of the biofilms. In addition, a viability reduction of 77% after a 20 s plasma treatment and a metabolism reduction of 90% after a 40 s plasma treatment time were observed for C. albicans. After such a treatment, the biofilms revealed an altered morphology of their cells by atomic force microscopy (AFM). Additionally, fluorescence microscopy and confocal laser scanning microscopy (CLSM) analyses of plasma‐treated biofilms showed that an inactivation of cells mainly appeared on the bottom side of the biofilms. Thus, the plasma inactivation of the overgrown surface reveals a new possibility to combat biofilms.
Cold physical plasma is a partially ionized gas expelling many reactive oxygen and nitrogen
species (ROS/RNS). Several plasma devices have been licensed for medical use in dermatology, and
recent experimental studies suggest their putative role in cancer treatment. In cancer therapies with
an immunological dimension, successful antigen presentation and inflammation modulation is a
key hallmark to elicit antitumor immunity. Dendritic cells (DCs) are critical for this task. However,
the inflammatory consequences of DCs following plasma exposure are unknown. To this end,
human monocyte-derived DCs (moDCs) were expanded from isolated human primary monocytes;
exposed to plasma; and their metabolic activity, surface marker expression, and cytokine profiles
were analyzed. As controls, hydrogen peroxide, hypochlorous acid, and peroxynitrite were used.
Among all types of ROS/RNS-mediated treatments, plasma exposure exerted the most notable
increase of activation markers at 24 h such as CD25, CD40, and CD83 known to be crucial for T cell
costimulation. Moreover, the treatments increased interleukin (IL)-1α, IL-6, and IL-23. Altogether,
this study suggests plasma treatment augmenting costimulatory ligand and cytokine expression in
human moDCs, which might exert beneficial effects in the tumor microenvironment.
Cold physical plasma (CPP), a partially ionized gas that simultaneously generates reactive oxygen and nitrogen species, is suggested to provide advantages in regenerative medicine. Intraoperative CPP therapy targeting pathologies related to diminished bone quality could be promising in orthopedic surgery. Assessment of a clinically approved plasma jet regarding cellular effects on primary bone marrow mesenchymal stromal cells (hBM-MSCs) from relevant arthroplasty patient cohorts is needed to establish CPP-based therapeutic approaches for bone regeneration. Thus, the aim of this study was to derive biocompatible doses of CPP and subsequent evaluation of human primary hBM-MSCs’ osteogenic and immunomodulatory potential. Metabolic activity and cell proliferation were affected in a treatment-time-dependent manner. Morphometric high content imaging analyses revealed a decline in mitochondria and nuclei content and increased cytoskeletal compactness following CPP exposure. Employing a nontoxic exposure regime, investigation on osteogenic differentiation did not enhance osteogenic capacity of hBM-MSCs. Multiplex analysis of major hBM-MSC cytokines, chemokines and growth factors revealed an anti-inflammatory, promatrix-assembling and osteoclast-regulating secretion profile following CPP treatment and osteogenic stimulus. This study can be noted as the first in vitro study addressing the influence of CPP on hBM-MSCs from individual donors of an arthroplasty clientele.
Gas plasma is an approved technology that generates a plethora of reactive oxygen species, which are actively applied for chronic wound healing. Its particular antimicrobial action has spurred interest in other medical fields, such as periodontitis in dentistry. Recent work has indicated the possibility of performing gas plasma-mediated biofilm removal on teeth. Teeth frequently contain restoration materials for filling cavities, e.g., resin-based composites. However, it is unknown if such materials are altered upon gas plasma exposure. To this end, we generated a new in-house workflow for three commonly used resin-based composites following gas plasma treatment and incubated the material with human HaCaT keratinocytes in vitro. Cytotoxicity was investigated by metabolic activity analysis, flow cytometry, and quantitative high-content fluorescence imaging. The inflammatory consequences were assessed using quantitative analysis of 13 different chemokines and cytokines in the culture supernatants. Hydrogen peroxide served as the control condition. A modest but significant cytotoxic effect was observed in the metabolic activity and viability after plasma treatment for all three composites. This was only partially treatment time-dependent and the composites alone affected the cells to some extent, as evident by differential secretion profiles of VEGF, for example. Gas plasma composite modification markedly elevated the secretion of IL6, IL8, IL18, and CCL2, with the latter showing the highest correlation with treatment time (Pearson’s r > 0.95). Cell culture media incubated with gas plasma-treated composite chips and added to cells thereafter could not replicate the effects, pointing to the potential that surface modifications elicited the findings. In conclusion, our data suggest that gas plasma treatment modifies composite material surfaces to a certain extent, leading to measurable but overall modest biological effects.
Pancreatic cancer is known for its tumor microenvironment (TME), which is rich in stromal and immune cells supporting cancer growth and therapy resistance. In particular, tumor-associated macrophages (TAMs) are known for their angiogenesis- and metastasis-promoting properties, which lead to the failure of conventional therapies for pancreatic cancer. Hence, treatment options targeting TAMs are needed. The C-C chemokine receptor type 4 (CCR4) is critical for immune cell recruitment into the TME, and in this paper we explore the effects of its genetic or immunotherapeutic blockade in pancreatic-cancer-bearing mice. Murine PDA6606 pancreatic cancer cells and murine peritoneal macrophages were used for in vitro migration assays. In vivo, a syngeneic, orthotropic pancreatic cancer model was established. Tumor growth and survival were monitored under prophylactic and therapeutic application of a CCR4 antagonist (AF-399/420/18025) in wildtype (CCR4wt) and CCR4-knockout (CCR4−/−) mice. Immune infiltration was monitored in tumor tissue sections and via flow cytometry of lysed tumors. PDA6606 cells induced less migration in CCR4−/− than in CCR4wt macrophages in vitro. Pancreatic TAM infiltration was higher, and survival was reduced in CCR4wt mice compared to CCR4−/− mice. Antagonizing CCR4 in wildtype mice revealed similar results as in CCR4−/− mice without antagonization. Prophylactic CCR4 antagonist application in wildtype mice was more efficient than therapeutic antagonization. CCR4 seems to be critically involved in TAM generation and tumor progression in pancreatic cancer. CCR4 blockade may help prolong the relapse-free period after curative surgery in pancreatic cancer and improve prognosis.